Literature DB >> 2708521

Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men.

A A Portale1, B P Halloran, R C Morris.   

Abstract

We asked this question: in normal humans, is either a normal dietary intake or normal serum concentration of phosphorus a determinant of the serum concentration of 1,25(OH)2D? In seven normal men whose dietary phosphorus was decreased from 2,300 to 625 mg/d, each intake for 8-9 d, under strictly controlled, normal metabolic conditions, we measured serum concentrations of 1,25(OH)2D daily, and concentrations of phosphorus hourly throughout a 24-h period, before and after restriction. Decreasing dietary phosphorus induced: (a) a 58% increase in serum levels of 1,25(OH)2D; (b) a 35% decrease in serum levels of phosphorus measured in the afternoon; (c) a 12% decrease in the 24-h mean serum level of phosphorus; but, (d) no decrease in morning fasting levels of phosphorus. Serum concentrations of 1,25(OH)2D varied inversely and significantly with 24-h mean concentrations of phosphorus (r = -0.77, P less than 0.001). When these data are combined with those of our prior study in which dietary phosphorus was varied over an extreme range, the relationship between serum levels of 1,25(OH)2D and 24-h mean serum levels of phosphorus is even stronger (r = -0.90, P less than 0.001). In the aggregate, the results demonstrate that in normal men, dietary phosphorus throughout a normal range and beyond, can finely regulate the renal production and serum concentration of 1,25(OH)2D, and provide evidence that this regulation is mediated by fine modulation of the serum concentration of phosphorus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2708521      PMCID: PMC303852          DOI: 10.1172/JCI114043

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Studies on calciferol metabolism. VII. The renal production of the biologically active form of vitamin D, 1,25-dihydroxycholecalciferol; species, tissue and subcellular distribution.

Authors:  R J Midgett; A M Spielvogel; J W Coburn; A W Norman
Journal:  J Clin Endocrinol Metab       Date:  1973-06       Impact factor: 5.958

2.  Control of 25-hydroxycholecalciferol metabolism by parathyroid glands.

Authors:  M Garabedian; M F Holick; H F Deluca; I T Boyle
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

3.  Regulation of 25-hydroxyvitamin D3-1-hydroxylase in vivo.

Authors:  H L Henry; R J Midgett; A W Norman
Journal:  J Biol Chem       Date:  1974-12-10       Impact factor: 5.157

4.  Vitamin D metabolism: the role of kidney tissue.

Authors:  R Gray; I Boyle; H F DeLuca
Journal:  Science       Date:  1971-06-18       Impact factor: 47.728

5.  25-Hydroxycholecalciferol-1-hydroxylase. Subcellular location and properties.

Authors:  R W Gray; J L Omdahl; J G Ghazarian; H F DeLuca
Journal:  J Biol Chem       Date:  1972-12-10       Impact factor: 5.157

6.  Regulation of 25-hydroxycholecalciferol-1-hydroxylase activity in kidney by parathyroid hormone.

Authors:  D R Fraser; E Kodicek
Journal:  Nat New Biol       Date:  1973-02-07

7.  Regulation of vitamin D metabolism: factors influencing the rate of formation of 1,25-dihydroxycholecalciferol by kidney homogenates.

Authors:  K W Colston; I M Evans; L Galante; I MacIntyre; D W Moss
Journal:  Biochem J       Date:  1973-07       Impact factor: 3.857

8.  The control of 25-hydroxyvitamin D metabolism by inorganic phosphorus.

Authors:  Y Tanaka; H F Deluca
Journal:  Arch Biochem Biophys       Date:  1973-02       Impact factor: 4.013

9.  Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D.

Authors:  A A Portale; B P Halloran; R C Morris
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

10.  Elevated secretion and action of serum parathyroid hormone in young adults consuming high phosphorus, low calcium diets assembled from common foods.

Authors:  M S Calvo; R Kumar; H Heath
Journal:  J Clin Endocrinol Metab       Date:  1988-04       Impact factor: 5.958

View more
  43 in total

Review 1.  Miscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and αKlotho).

Authors:  Emily G Farrow; Erik A Imel; Kenneth E White
Journal:  Best Pract Res Clin Rheumatol       Date:  2011-10       Impact factor: 4.098

2.  Evidence for a bone-kidney axis regulating phosphate homeostasis.

Authors:  L Darryl Quarles
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

Review 3.  Nephrology, dialysis and transplantation.

Authors:  K Farrington; P Sweny
Journal:  Postgrad Med J       Date:  1990-07       Impact factor: 2.401

Review 4.  Recent advances in renal phosphate handling.

Authors:  Emily G Farrow; Kenneth E White
Journal:  Nat Rev Nephrol       Date:  2010-02-23       Impact factor: 28.314

5.  Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice.

Authors:  Emily G Farrow; Xijie Yu; Lelia J Summers; Siobhan I Davis; James C Fleet; Matthew R Allen; Alexander G Robling; Keith R Stayrook; Victoria Jideonwo; Martin J Magers; Holly J Garringer; Ruben Vidal; Rebecca J Chan; Charles B Goodwin; Siu L Hui; Munro Peacock; Kenneth E White
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

6.  Interaction of Serum Phosphate with Age as Predictors of Cardiovascular Risk Scores in Stable Renal Transplant Recipients.

Authors:  Jillian Kerry; Holly Mansell; Hamdi Elmoselhi; Mike Moser; Ahmed Shoker
Journal:  Int J Angiol       Date:  2016-12-12

7.  Parathyroid hormone gene expression in hypophosphatemic rats.

Authors:  R Kilav; J Silver; T Naveh-Many
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

Review 8.  Post-renal transplantation hypophosphatemia.

Authors:  Khashayar Sakhaee
Journal:  Pediatr Nephrol       Date:  2009-07-15       Impact factor: 3.714

9.  Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro.

Authors:  E Slatopolsky; J Finch; M Denda; C Ritter; M Zhong; A Dusso; P N MacDonald; A J Brown
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

10.  Serum phosphorus levels associate with coronary atherosclerosis in young adults.

Authors:  Robert N Foley; Allan J Collins; Charles A Herzog; Areef Ishani; Philip A Kalra
Journal:  J Am Soc Nephrol       Date:  2008-11-05       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.